Federated Hermes’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.6K Buy
3,705
+1,309
+55% +$4.79K ﹤0.01% 1769
2025
Q1
$10.4K Buy
2,396
+285
+14% +$1.23K ﹤0.01% 1799
2024
Q4
$6.76K Buy
2,111
+503
+31% +$1.61K ﹤0.01% 1873
2024
Q3
$4.6K Buy
1,608
+161
+11% +$460 ﹤0.01% 1867
2024
Q2
$4.05K Sell
1,447
-9,243
-86% -$25.9K ﹤0.01% 1861
2024
Q1
$30.4K Sell
10,690
-975
-8% -$2.77K ﹤0.01% 1677
2023
Q4
$47.7K Sell
11,665
-112,939
-91% -$462K ﹤0.01% 1655
2023
Q3
$396K Sell
124,604
-100,081
-45% -$318K ﹤0.01% 1404
2023
Q2
$746K Sell
224,685
-1,670,231
-88% -$5.55M ﹤0.01% 1239
2023
Q1
$4.04M Sell
1,894,916
-998,694
-35% -$2.13M 0.01% 755
2022
Q4
$7.78M Buy
2,893,610
+292,666
+11% +$787K 0.02% 599
2022
Q3
$8.43M Buy
2,600,944
+8,932
+0.3% +$28.9K 0.02% 566
2022
Q2
$12.6M Buy
2,592,012
+1,561,269
+151% +$7.62M 0.03% 499
2022
Q1
$7.85M Buy
1,030,743
+943,875
+1,087% +$7.19M 0.02% 666
2021
Q4
$802K Buy
86,868
+41,162
+90% +$380K ﹤0.01% 1356
2021
Q3
$651K Sell
45,706
-162,854
-78% -$2.32M ﹤0.01% 1431
2021
Q2
$3.47M Sell
208,560
-385,190
-65% -$6.4M 0.01% 936
2021
Q1
$10.8M Buy
593,750
+583,344
+5,606% +$10.6M 0.02% 643
2020
Q4
$78K Buy
10,406
+4,648
+81% +$34.8K ﹤0.01% 1769
2020
Q3
$22K Sell
5,758
-163
-3% -$623 ﹤0.01% 1882
2020
Q2
$23K Sell
5,921
-369
-6% -$1.43K ﹤0.01% 1846
2020
Q1
$20K Buy
+6,290
New +$20K ﹤0.01% 1789
2019
Q4
Sell
-3,102
Closed -$20K 2278
2019
Q3
$20K Buy
+3,102
New +$20K ﹤0.01% 1825